Idiopathic Intracranial Hypertension Management

Introduction

Idiopathic intracranial hypertension (IIH) can be classified into typical, atypical, fulminant, and IIH without papilledema or in ocular remission, with typical IIH characterized by female patients of reproductive age with a BMI >30 kg/m², as recommended by the Journal of Neurology, Neurosurgery and Psychiatry 1

The modified Dandy criteria require an opening pressure of the cerebrospinal fluid of at least 25 cm H₂O for diagnosis, as per the Journal of Neurology, Neurosurgery and Psychiatry 2, 1, 3
The following table summarizes the diagnostic criteria:

Diagnostic Criterion	Description
Evidence of increased ICP	Elevated opening pressure
Normal neuroimaging	No evidence of mass lesions or other abnormalities
Normal CSF composition	Normal glucose, protein, and cell count
Normal neurological examination	Except for papilledema and possible sixth nerve palsy

Neurological examination should be normal except for possible papilledema and sixth nerve palsy, with other cranial nerve involvement suggesting alternative diagnosis, as recommended by the Journal of Neurology, Neurosurgery and Psychiatry 1
Neuroimaging should include urgent MRI brain within 24 hours (or CT if MRI unavailable) and CT or MR venography to exclude cerebral sinus thrombosis, with no evidence of hydrocephalus, mass, structural or vascular lesion, as recommended by the American Academy of Neurology 1
All patients with papilledema should have documented visual acuity, pupil examination, formal visual field assessment, dilated fundal examination to grade papilledema, and BMI calculation, according to the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1
Serial optic nerve head photographs, Optical Coherence Tomography (OCT) imaging, and Transorbital ultrasound can be used for monitoring, as recommended by the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1

First-line treatment for IIH is Acetazolamide, with a starting dose of 250-500 mg twice daily, which can be increased to 2-4 g daily based on tolerance, and patients should be cautioned about side effects, as stated by the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1
Alternative treatments include Topiramate, Zonisamide, Candesartan, Venlafaxine, and Botulinum toxin A, as suggested by the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1
Topiramate may be considered as an alternative to acetazolamide, with multiple beneficial mechanisms, including weight loss promotion, migraine control, and carbonic anhydrase inhibition, but should not be used in pregnancy due to higher rates of fetal abnormalities, as stated by the Journal of Neurology, Neurosurgery and Psychiatry 1

CSF shunting is preferred due to lower revision rate, while optic nerve sheath fenestration and venous sinus stenting are alternative options, as recommended by the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1
Shunt revision should not be routinely undertaken unless there is papilledema and risk of visual deterioration, according to the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1
Surgical interventions, such as optic nerve sheath fenestration, cerebrospinal fluid (CSF) shunting, and transverse sinus stenting, are indicated when medical therapy fails, visual function deteriorates, or headaches persist despite medical management, with CSF shunting preferred due to a lower revision rate, as recommended by the American College of Radiology and the Journal of Neurology, Neurosurgery and Psychiatry 4, 1

Weight loss is the only disease-modifying therapy for typical IIH, and patients with a body mass index (BMI) >30 kg/m² should be advised on weight management, with a weight loss of up to 15% of body weight may be necessary to achieve remission, as recommended by the American College of Cardiology and the Journal of Neurology, Neurosurgery and Psychiatry 1

Multidisciplinary communication among clinicians throughout pregnancy, delivery, and postpartum is recommended, and Acetazolamide and Topiramate should be avoided during pregnancy, as stated by the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1
In pregnant patients, multidisciplinary communication between specialists is crucial, and acetazolamide is not recommended during pregnancy according to manufacturers, highlighting the need for alternative management strategies, as recommended by the Journal of Neurology, Neurosurgery and Psychiatry 4, 1

Patients who were asymptomatic at presentation may remain asymptomatic during recurrence, requiring longer-term follow-up, as suggested by the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1
Failure to optimize ICP may render migrainous headaches difficult to treat, and preventative drugs need to be started slowly and increased to therapeutic doses for at least 3 months to enable a proper trial, according to the Journal of Neurology, Neurosurgery and Psychiatry guidelines 1
Regular ophthalmological monitoring is recommended to evaluate visual acuity, visual fields, and fundus examination, and diagnostic LP should be considered if there is significant visual deterioration, as recommended by the American Academy of Ophthalmology and the Journal of Neurology, Neurosurgery and Psychiatry 1, 5, 6
Early review after intervention (24-48 hours), intermediate follow-up (10-14 days or 3-6 weeks), and late follow-up (3-6 months) are crucial for effective management, with a strength of evidence level of B, as recommended by the American Academy of Neurology 1, 7

Non-obese patients should be investigated for secondary causes of intracranial hypertension, as the underlying pathophysiology may differ from that in obese patients, as recommended by the Journal of Neurology, Neurosurgery and Psychiatry 4, 1
Elderly patients may present atypically and have other causes of altered mental status, as recommended by the Journal of Infection guidelines 8
New or worsening neurological findings should be referred to specialists, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 9

The prognosis is generally good with accurate diagnosis and timely initiation of treatment, particularly regarding preservation of vision, emphasizing the importance of prompt recognition and management of pseudotumor cerebri, as recommended by the American College of Radiology and the Journal of Neurology, Neurosurgery and Psychiatry 4, 1